Alkermes (ALKS) Long-Term Deferred Tax (2011 - 2026)

Alkermes' (ALKS) quarterly Long-Term Deferred Tax came in at $134.8 million in Q1 2026, down 11.39% year-on-year from $152.1 million in Q1 2025, and up 7.15% on a QoQ basis from $125.8 million in Q4 2025.

Alkermes (ALKS) Long-Term Deferred Tax (2011 - 2026) Analysis & Trends

Alkermes (ALKS) has 16 years of Long-Term Deferred Tax data on file, last reported at $134.8 million in Q1 2026.

  • On a quarterly basis, Long-Term Deferred Tax fell 11.39% year-over-year to $134.8 million in Q1 2026; TTM through Mar 2026 was $134.8 million, a 11.39% decrease from a year earlier, with the FY2025 full-year figure at $125.8 million, down 18.74% from the prior year.
  • Long-Term Deferred Tax for Q1 2026 stood at $134.8 million, up from $125.8 million in the prior quarter.
  • Over the last five years, Long-Term Deferred Tax for ALKS reached as high as $195.9 million in Q4 2023 and fell as low as $112.5 million in Q1 2022.
  • Historically, Long-Term Deferred Tax has averaged $147.9 million across 5 years, with a median of $152.1 million in 2025.
  • Across the five-year window, Long-Term Deferred Tax surged 70.97% in 2023 and retreated 20.96% in 2024, its largest moves.
  • Year by year, Long-Term Deferred Tax stood at $114.6 million in 2022, then jumped by 70.97% to $195.9 million in 2023, then declined by 20.96% to $154.8 million in 2024, then fell by 18.74% to $125.8 million in 2025, then gained by 7.15% to $134.8 million in 2026.
  • Per Business Quant data, the three most recent Long-Term Deferred Tax figures were $134.8 million in Q1 2026, $125.8 million in Q4 2025, and $130.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Alkermes 9.72 Bn 9.21 Bn 331.33 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 134.81 Mn
Dec 31, 2025 125.82 Mn
Sep 30, 2025 130.34 Mn
Jun 30, 2025 155.53 Mn
Mar 31, 2025 152.14 Mn
Dec 31, 2024 154.84 Mn
Sep 30, 2024 159.96 Mn
Jun 30, 2024 167.38 Mn
Mar 31, 2024 182.54 Mn
Dec 31, 2023 195.89 Mn
Sep 30, 2023 162.18 Mn
Jun 30, 2023 153.15 Mn
Mar 31, 2023 151.23 Mn
Dec 31, 2022 114.57 Mn
Sep 30, 2022 137.15 Mn
Jun 30, 2022 123.70 Mn
Mar 31, 2022 112.52 Mn
Dec 31, 2021 81.83 Mn
Sep 30, 2021 84.50 Mn
Jun 30, 2021 75.64 Mn